Showing posts with label Global Hemostats Market Research Report. Show all posts
Showing posts with label Global Hemostats Market Research Report. Show all posts
Ethicon US LLC (U.S.) is Dominating the Hemostats Market Followed by Pfizer and C.R. Bard Inc.

Ethicon US LLC (U.S.) is Dominating the Hemostats Market Followed by Pfizer and C.R. Bard Inc.


Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostats), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) and Forecast to 2024.

Global Hemostats Market is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.


Key Drivers of Global Hemostats Market:

Some of the major factors driving the market for hemostats market are increasing number of surgeries, technological advancement, increasing healthcare expenditure and infrastructure. These factors are increasing the demand for different heomostatic agents.

·         Reluctance of surgeons towards new products may hinder the growth of this market.

·         The weak reimbursement scenario will hamper the growth of the market for new and innovative therapies or hemostats products, causing companies to withdraw from the market thus increasing the hospital costs putting all burdens onto the patient for treatment.

This report consists of below pages:

             No of pages: 278
             No of Figures: 241
             No of Tables: 237


Key Points of Global Hemostats Market:

Ethicon US LLC (U.S.) is  dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited, Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. among other companies.

·         Combination agents market is growing with the highest CAGR.

·         Thrombin based hemostats is driving the market with the highest market share.

·         Surgery is dominating the application segment in the hemostats market.

Scope of the Report:

The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats. In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.

On the basis of application, the market is segmented into surgery and wound closure.

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.


Key Topics Covered:

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET, BY INDICATION
7. HEMOSTATS MARKET, BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
10. HEMOSTATS MARKET, COMPANY PROFILES
      10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
      10.2. PFIZER
      10.3. C.R. BARD
      10.4. BAXTER
      10.5. VASCULAR SOLUTIONS, INC.
      10.6. B.BRAUN MELSUNGEN
      10.7. 3-D MATRIX, LTD
      10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
      10.9. ANIKA THERAPEUTICS, INC.
      10.10. ARCH THERAPEUTICS INC.
      10.11. BIOM’UP SAS
      10.12. CRYOLIFE, INC.
      10.13. GAMMA THERAPEUTICS, INC.
      10.14. HEMOSTASIS, LLC
      10.15. MEDTRADE PRODUCTS LTD.
      10.16. INTEGRA LIFESCIENCES CORPORATION
      10.17. MEDLINE INDUSTRIES, INC.
      10.18. HEMOTEC MEDICAL GMBH
      10.19. STRYKER
      10.20. HEMOSTASIS, LLC.
      10.21. CSL BEHRING
      10.22. MALLINCKRODT PLC.
      10.23. EQUIMEDICAL, B.V.

Related Report

Global Hernia Repair Devices Market – Industry Trends and Forecast to 2024

Global Hernia Repair Devices Market By Product Type, End User, Geography (North America, Europe, APAC, South America, MEA)–Industry Trends and Forecast to 2024


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818

Powered by Blogger.